Actemra (tocilizumab) lawsuits claim that Genentech, a subsidiary of Roche, failed to warn rheumatoid arthritis (RA) patients about Actemra’s side effects, including heart attacks, heart failure and even death. According to Actemra attorneys, Genentech negligently advertised its arthritis drug to patients by claiming it was safer than the competitor medications. Tocilizumab side effects also include lung complications and pancreatitis, which has a 50 percent risk of death. None of these side effects appear on the Actemra warning label. [Original Article]
